Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
John Koreth;Ken Ichi Matsuoka;Haesook T. Kim;Sean M. McDonough.
The New England Journal of Medicine (2011)
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo
Emmanuel Zorn;Erik A. Nelson;Mehrdad Mohseni;Fabrice Porcheray.
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Philippe Armand;Haesook T. Kim;Brent R. Logan;Zhiwei Wang.
Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation
Philippe Armand;Haesook T. Kim;Corey S. Cutler;Vincent T. Ho.
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.
Emmanuel Zorn;Haesook T. Kim;Haesook T. Kim;Stephanie J. Lee;Stephanie J. Lee;Blair H. Floyd;Blair H. Floyd.
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission
David B. Miklos;David B. Miklos;Haesook T. Kim;Haesook T. Kim;Katherine H. Miller;Katherine H. Miller;Luxuan Guo;Luxuan Guo.
Cumulative Incidence in Competing Risks Data and Competing Risks Regression Analysis
Haesook T. Kim.
Clinical Cancer Research (2007)
Rituximab for steroid-refractory chronic graft-versus-host disease.
Corey Cutler;David Miklos;Haesook T. Kim;Nathaniel Treister.
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
Matthew S. Davids;Haesook T. Kim;Pavan Bachireddy;Caitlin Costello.
The New England Journal of Medicine (2016)
Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
Ken-ichi Matsuoka;John Koreth;Haesook T. Kim;O. Gregory Bascug.
Science Translational Medicine (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: